IMMUNOGEN
Live / Registered — Registered (as of 28 Jun 2022)
What this means for you
Registered since 28 Jun 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Jun 2028: the §8 declaration of use).
Record
- Serial number
- 97097296
- Registration number
- 6774914
- Mark type
- Word mark
- Filed
- 28 Oct 2021
- Published for opposition
- 12 Apr 2022
- Registered
- 28 Jun 2022
- Next maintenance filing
- §8 declaration of use, due by 28 Jun 2028 (grace period to 28 Dec 2028)
- Attorney of record
- Matthew O. Brady
Goods and services
- Class 005 — Pharmaceuticals: House mark for pharmaceutical products for human use, namely, pharmaceutical preparations for treatment of cancer; house mark for pharmaceutical products for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
Owner
- ImmunoGen, Inc., North Chicago, IL, US
- ImmunoGen, Inc., Waltham, MA, US
- ImmunoGen, Inc., Waltham, MA, US
Prior registrations
Prosecution history
- 24 Apr 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Apr 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Apr 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Apr 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Apr 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 12 Apr 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Apr 2022 — PUBLISHED FOR OPPOSITION
- 23 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Mar 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Mar 2022 — ASSIGNED TO EXAMINER
- 10 Nov 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Nov 2021 — NEW APPLICATION ENTERED